Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 9 di 9
Titolo Data di pubblicazione Autori Tipo File Abstract
Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy 2006 G. Jovic + Article (author) -
Biomarker expression and survival after primary chemotherapy for breast cancer 2007 G. Jovic + Conference Object -
Preliminary safety data of preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2 positive operable breast cancer 2007 G. Jovic + Conference Object -
Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles. 2007 G. Jovic + Article (author) -
Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy 2007 G. Jovic + Article (author) -
Exact method for analysis after single-stage and two-stage phase II cancer clinical trial 2008 G. Jovic Conference Object -
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases : impact on patient management 2008 G. Jovic + Article (author) -
Letrozole versus letrozole plus Lapatinib (GW572016) in hormone-sensitive, HER2-negative operable breast cancer : a double-blind, randomized, phase II study with biomarker evaluation (EGF109077-LAP107692/LETLOB) 2008 G. Jovic + Article (author) -
Preoperative chemotherapy plus lapatinib or trastuzumab or both in HER2-positive operable breast cancer (CHERLOB Trial) 2008 JOVIC, GORDANA + Article (author) -
Mostrati risultati da 1 a 9 di 9
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile